A2: Business

By

The Detroit Free Press reports that Esperion Therapeutics, founded by Ann Arbor entrepreneur and scientist Roger Newton, has filed this week for an initial public offering. According to the report, Esperion’s filing with the U.S. Securities & Exchange Commission states that the firm intends to raise $70 million and would be listed on Nasdaq with the symbol ESPR. [Source]